EG10517A - Method of inhibiting the hydrolysis of acetylsalicylic acid and propoxyphene hydrochloride - Google Patents

Method of inhibiting the hydrolysis of acetylsalicylic acid and propoxyphene hydrochloride

Info

Publication number
EG10517A
EG10517A EG401/71*UA EG40171A EG10517A EG 10517 A EG10517 A EG 10517A EG 40171 A EG40171 A EG 40171A EG 10517 A EG10517 A EG 10517A
Authority
EG
Egypt
Prior art keywords
hydrolysis
inhibiting
acetylsalicylic acid
propoxyphene hydrochloride
propoxyphene
Prior art date
Application number
EG401/71*UA
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of EG10517A publication Critical patent/EG10517A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Specific Conveyance Elements (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Processing Of Meat And Fish (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG401/71*UA 1970-09-15 1971-09-13 Method of inhibiting the hydrolysis of acetylsalicylic acid and propoxyphene hydrochloride EG10517A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7250470A 1970-09-15 1970-09-15
US17787071A 1971-09-03 1971-09-03

Publications (1)

Publication Number Publication Date
EG10517A true EG10517A (en) 1976-01-31

Family

ID=26753427

Family Applications (1)

Application Number Title Priority Date Filing Date
EG401/71*UA EG10517A (en) 1970-09-15 1971-09-13 Method of inhibiting the hydrolysis of acetylsalicylic acid and propoxyphene hydrochloride

Country Status (18)

Country Link
AR (1) AR192893A1 (enrdf_load_stackoverflow)
AT (1) AT309668B (enrdf_load_stackoverflow)
BE (1) BE772610A (enrdf_load_stackoverflow)
CA (1) CA997678A (enrdf_load_stackoverflow)
DE (1) DE2145947C3 (enrdf_load_stackoverflow)
DK (1) DK131368B (enrdf_load_stackoverflow)
EG (1) EG10517A (enrdf_load_stackoverflow)
ES (1) ES395080A1 (enrdf_load_stackoverflow)
FR (1) FR2106539B1 (enrdf_load_stackoverflow)
GB (1) GB1317234A (enrdf_load_stackoverflow)
HK (1) HK54776A (enrdf_load_stackoverflow)
IE (1) IE35644B1 (enrdf_load_stackoverflow)
NL (1) NL174428C (enrdf_load_stackoverflow)
NO (1) NO134931C (enrdf_load_stackoverflow)
OA (1) OA03913A (enrdf_load_stackoverflow)
PH (1) PH10793A (enrdf_load_stackoverflow)
RO (1) RO61105A (enrdf_load_stackoverflow)
SE (1) SE388124B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5115094B2 (enrdf_load_stackoverflow) * 1972-11-01 1976-05-14
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors

Also Published As

Publication number Publication date
DE2145947B2 (de) 1973-02-22
SE388124B (sv) 1976-09-27
DE2145947A1 (de) 1972-03-30
FR2106539A1 (enrdf_load_stackoverflow) 1972-05-05
NO134931B (enrdf_load_stackoverflow) 1976-10-04
BE772610A (fr) 1972-03-15
NO134931C (enrdf_load_stackoverflow) 1977-01-12
IE35644B1 (en) 1976-04-14
PH10793A (en) 1977-09-07
DK131368C (enrdf_load_stackoverflow) 1975-12-01
FR2106539B1 (enrdf_load_stackoverflow) 1974-11-15
IE35644L (en) 1972-03-15
OA03913A (fr) 1975-08-14
RO61105A (enrdf_load_stackoverflow) 1976-08-15
GB1317234A (en) 1973-05-16
CA997678A (en) 1976-09-28
DK131368B (da) 1975-07-07
ES395080A1 (es) 1974-12-01
DE2145947C3 (de) 1973-09-27
AR192893A1 (es) 1973-03-21
HK54776A (en) 1976-09-17
NL174428C (nl) 1984-06-18
NL7112647A (enrdf_load_stackoverflow) 1972-03-17
NL174428B (nl) 1984-01-16
AT309668B (de) 1973-08-27

Similar Documents

Publication Publication Date Title
JPS5533402A (en) Manufacture of 55aroylpyrrole acetic acid and its salts
IL38235A0 (en) Triglyceride hydrolysis and assay
ZA711085B (en) Phosphoric acid esters and their use as pesticides
JPS5384945A (en) Method for production of 155alkylprostaglandin and like
ZA71948B (en) Method of interconnecting parts
PH10336A (en) Nono-chromone-2-carboxylic acid and method and composition for the treatment of asthma
JPS57131761A (en) Manufacture of aminophenylcycloamidine and salts of same
IL35797A (en) 3-propionyl-salicylic acid and the preparation of 3-methylflavone-8-carboxylic acid esters
CA947333A (en) Reinforced flexible connector and method of manufacture thereof
JPS5444663A (en) Manufacture of aminophenyllcycloamidine and its salts
CS194154B2 (en) Method of preparing 5-fluor-2-methyl-1-/4'-methyl-sulphinyl-benzylidene/-3-indenylacetic acid
ZA717133B (en) Esters of mandeloylaminocephalosporanic acids
AU3457171A (en) Fastener and method of manufacture thereof
JPS5686151A (en) Manufacture of alphaaisopropylidenee11 azetidineacetate and its acid
EG10517A (en) Method of inhibiting the hydrolysis of acetylsalicylic acid and propoxyphene hydrochloride
IL39246A0 (en) The preparation of n-substituted n-chloromethyl-carbamic acid esters and thiolesters
PH10908A (en) Pregnanoic acid esters and the compositions thereof
IL37606A (en) Method of inhibiting the hydrolysis of acetylsalicylic acid and d-propoxyphene hydrochloride
IL43396A (en) Process for the preparation of 2-benzimidazole-carbamic acid alkyl and benzyl esters
IL36521A0 (en) New metabenzoylphenylacetic acid esters and process of preparation
IL38057A (en) Thiodicarbamic acid diaryl esters and n-urea sulfides
ZM13171A1 (en) Method of inhibiting the hydrolysis of acetysalicylic acid and d-propexyphene hydrochloride
IL36583A0 (en) The pesticidal use of phosphoric acid esters
EG10332A (en) Herbicides of thiolcarbamic acid esters
CA942137A (en) Method of preventing fires along roadsides and alike